Breaking News

Mixed Results With Metformin in Men Taking ADT for Prostate Cancer

(MedPage Today) — Metformin failed to prevent metabolic syndrome in men receiving hormone therapy for prostate cancer, but improved risk factors associated with the syndrome, an abbreviated randomized trial showed. The proportion of patients affected…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button